We look forward to Dr. Eoin Flanagan joining our December 2024 AEA Provider Monthly Education Series and presenting Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).
This session is scheduled for December 12, 2024 at 4:00 PM Eastern US Time and offered via Zoom.
Members of the AEA Medical Advisory Board and Clinicians Network and participating fellowship programs receive monthly emails including links to register for each session.
A recording of the didactic portion of Dr. Flanagan’s session will be posted here after the session.
Dr. Flanagan’s session will achieve the following:
Review relevant references for the session:
1. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, Reindl M, Saiz A, Sato DK, Rostasy K, Paul F, Pittock SJ, Fujihara K, Palace J. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023 Mar; 22 (3):268-282 Epub 2023 Jan 24 PMID: 36706773
2. Flanagan EP, Tillema JM. Myelin Oligodendrocyte Glycoprotein antibody-associated disease (MOGAD): Clinical features and diagnosis. 2022 UpToDate, Waltham, MA.
3. Cacciaguerra L, Flanagan EP. Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders. Neurol Clin. 2024 Feb; 42 (1):77-114 Epub 2023 Aug 07 PMID: 37980124 PMCID: PMC10658081 DOI: 10.1016/j.ncl.2023.06.009
Learn more about Dr. Flanagan.
Learn more about the AEA Provider Monthly Didactic + Case Discussion Series.
Click here and FILTER BY “AEA Monthly Didactic” to access all didactic recordings.